Clinical Trial Update: ARC in Hemorrhagic Stroke

View source ↗

Summary

UNC-Chapel Hill-led clinical trial evaluating augmented renal clearance in patients with hemorrhagic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Stroke

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Hemorrhagic Stroke, Augmented Renal Clearance | Status: COMPLETED